Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. - Wikidata - awgldk - TriplyDB

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

http://www.wikidata.org/entity/Q33569425

about

Glucagon-like peptide-1: The missing link in the metabolic clock?Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 Stimulation of incretin secreting cells Pancreatic regulation of glucose homeostasis Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects.Acute selective bioactivity of grape seed proanthocyanidins on enteroendocrine secretions in the gastrointestinal tract.The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.Progressive change of intra-islet GLP-1 production during diabetes development Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs.Gut chemosensing mechanisms.Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression.The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway.Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice Therapy in the early stage: incretins.Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.Insulin-regulated glucagon-like peptide-1 release from L cells: actin' out.Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.Molecular mechanisms underlying nutrient detection by incretin-secreting cells.Odyssey between Scylla and Charybdis through storms of carbohydrate metabolism and diabetes: a career retrospective.Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.Incretin hormones and the satiation signal.Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.Rationale use of GLP-1 receptor agonists in patients with type 1 diabetes.Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.Gut feedback mechanisms and food intake: a physiological approach to slow carbohydrate bioavailability.Mechanisms for the cardiovascular effects of glucagon-like peptide-1.The incretin hormone GLP-1 and mechanisms underlying its secretion.Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell.Evidence for paracrine/autocrine regulation of GLP-1-producing cells.The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis.Insulin detemir enhances proglucagon gene expression in the intestinal L cells via stimulating β-catenin and CREB activities.Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?Chylomicrons stimulate incretin secretion in mouse and human cells.GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs.Inhibition of Vascular c-Jun N-Terminal Kinase 2 Improves Obesity-Induced Endothelial Dysfunction After Roux-en-Y Gastric Bypass.

P2860

Q26749185-10D4CCCC-5E02-474A-AAC4-96037680D67A Q26752511-AAE13DD3-3ED2-4596-8C2F-73ED9AB0BE3C Q26765259-0881E4D2-28C0-4ECB-913B-A5E99D947F2F Q26766485-0B325C3E-93B3-450F-910E-BD88DD9987EE Q28564632-CF620F71-4BDB-4AD3-BED3-410EDE48748D Q28565218-453150BD-B247-45CD-8DBC-700DC6B6C0F9 Q33585620-12C96BC6-EC8E-4A6E-8812-10BF7C751493 Q33811018-EFDDD0DC-90F0-4AB3-B2CE-C63766AA5FCD Q33867998-D0484BC8-5692-4C96-A172-88F02C371BED Q33958801-71E17C64-508E-4933-807B-F805BDDD4355 Q34021138-46FBF7E8-4BAB-48D9-A880-409FE929834F Q34980692-42FC2B01-EBA4-4181-8D38-C2043654AC96 Q35183915-D5416F19-FCE9-4436-93D3-F2921879790E Q35372850-914FE02F-167A-48A0-8A08-3702891BEC86 Q35593684-307908BD-0DB6-4293-B0F3-2EA20C89FD19 Q36477333-C7DCC4AE-9149-49B1-A887-3EA5E41B3C9C Q36783865-2AD33364-C729-42A1-A470-CC53745584FE Q36976775-9EB8A078-B4E5-4964-9B04-5FBF444DBE7A Q37482908-96DCE64B-3DE4-4473-BC6C-5FA3F8EA2050 Q37598515-171F422A-7AD5-48C5-8A84-DB0D789F8FF7 Q37702790-83994929-E767-4D57-AB5E-293A2200D512 Q37786146-F66AE5CC-28F7-4E8B-B335-D240E43D2A20 Q37911549-94BE4EDB-5ADF-4EEB-873F-3A064A5A1435 Q38048602-5C1D6A48-9CF3-4AB8-8D89-3AF8ACE96720 Q38072203-055112F0-AF40-4800-97AD-7F79C9713BA5 Q38078816-5FE28275-2DDA-43F1-BC1A-EA8A1F0FAA54 Q38129805-37700B83-6FAA-45D8-B5D5-1E9A2EA2F0CE Q38165106-C103F7B8-F9D3-4220-B98E-243C74A0FBED Q38357251-F2CDF2F8-633E-4FA4-B498-6A6EFFE3A660 Q38589032-913EE875-1B91-4415-A472-C38A18196BF0 Q38861610-BBB2BB10-DCB6-47B5-9E4B-C4705C2DE844 Q38981245-048043E0-FD0C-4D9B-8C72-5A791DB21360 Q39041700-70B213B2-0860-4F7F-907A-92E80C6F0929 Q39103643-858981DA-873F-4125-8936-9DA6DB5C6666 Q39281417-642A5138-0E27-4836-887B-F443C80D6C5A Q39312100-30684DA4-9FD0-45D0-AD2A-67DEB4100A2B Q42730475-422574D5-F3DA-4FAD-B21F-C87DCA98C214 Q46312766-6C50E9CF-299F-4229-9720-7D390E5839D9 Q46627574-E9C8AAE3-BBA0-498D-BA84-4F44E4A37BC2 Q47110705-434D9914-B737-40BD-93A4-FE6DD8C6A656

P2860

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

http://www.wikidata.org/entity/Q33569425

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@ast

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@en

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@nl

type

label

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@ast

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@en

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@nl

prefLabel

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@ast

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@en

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@nl

P1433

Q33569425-D33903AB-6064-4954-A467-5DE316916995

P1476

Q33569425-C246561B-7467-41B6-9210-BE3B9FE0A97E

P2093

Q33569425-6886191C-F71E-4D30-AAF7-C491A47F3F48

Q33569425-70C248BF-9D7C-4607-87B8-4DD3EBDC11B5

Q33569425-75519F4C-7F4E-474D-B0EC-FCE0EA941E30

Q33569425-8222F296-392F-4F97-B831-EA45B18EF2A1

Q33569425-DA142ADC-7633-43B3-871B-B38F6F06ADE1

P2860

Q33569425-051F0671-B378-4A10-B8C2-DACC66513CBD

Q33569425-057A9DCF-696F-4580-8ED2-AE9EC4C7D605

Q33569425-080F98C7-912F-42FC-AF3B-8334FCFEE4CE

Q33569425-0A92670F-6FE9-46D4-BC75-0E3C12E28242

Q33569425-15C49022-94ED-410D-AD7D-623D39D1D2F8

Q33569425-1A804700-4A5B-4903-A08D-7EF75BD582F9

Q33569425-261BB5B1-CF56-4DCB-991B-C64B2EDAE55C

Q33569425-2694312D-F54A-4B8A-AD10-BF4827062D2A

Q33569425-2927B898-6E03-44C8-9A0A-CFD9B97AF98A

Q33569425-299D31FA-5931-405C-96D5-0F52A4344722

P304

Q33569425-20FC0006-CA2A-4C29-A97C-EA284E7597D6

P31

Q33569425-23E5D23E-20FC-4342-A2A6-D8009101C4F4

P356

Q33569425-9D5B3452-CFF7-406A-8BEE-75723780E467

P407

Q33569425-36866583-DE73-4B49-A539-2412E7398D94

P433

Q33569425-1581D2EF-CE95-4E5A-8BEE-D8D5A40862C7

P478

Q33569425-A355C95A-6403-4B27-8BFC-FD4871C95C4A

P50

Q33569425-5CFA6BCB-E3D9-4217-A5EA-46C6553CC6DC

P577

Q33569425-97B25654-F618-448F-B935-473C4847D81A

P698

Q33569425-488AAA43-18DF-48A4-9060-B3FAAB68A1D6

P921

Q33569425-072CE0D2-2283-4C0C-BB76-97ABF2969E19

P932

Q33569425-9F640FD0-8B0E-4D86-8B62-D27A982FDF53

P356

P1433

P1476

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

@en

P2093

Christopher J Rhodes

http://www.w3.org/2001/XMLSchema#string

Gareth E Lim

http://www.w3.org/2001/XMLSchema#string

Guan J Huang

http://www.w3.org/2001/XMLSchema#string

Nina Flora

http://www.w3.org/2001/XMLSchema#string

Patricia L Brubaker

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

Role of leptin in the regulation of glucagon-like peptide-1 secretion

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells

Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.

Tyrosine kinases are required for catecholamine secretion and mitogen-activated protein kinase activation in bovine adrenal chromaffin cells.

IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.

Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.

P304

580-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2008-0726

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18818290

http://www.w3.org/2001/XMLSchema#string

P921

P932

5393261

http://www.w3.org/2001/XMLSchema#string